115 The frequency of intermediate monocytes before treatment is a candidate biomarker of clinical response to secukinumab in of psoriasis
Autor: | J. Hardman-Smart, R. Andres Ejarque, S. Solanky, I. Tosi, K. Grys, J. Barker, C. Griffiths, N.J. Reynolds, C. Smith, R.B. Warren, P. Di Meglio, P. Consortium |
---|---|
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Journal of Investigative Dermatology. 142:S200 |
ISSN: | 0022-202X |
Databáze: | OpenAIRE |
Externí odkaz: |